|
|
|
Company
Name |
Short
Summary |
| Acceleron Pharma |
Acceleron Pharma is focused on the development of products for the treatment of patients with cancer and orphan diseases. |
| Aegerion Pharmaceuticals |
Aegerion Pharmaceuticals is focused on the research and development of cholesterol-lowering drugs for the treatment of cardiovascular and metabolic disease. |
| Agios Pharmaceuticals |
Agios Pharmaceuticals is focused on the research and development of drugs impacting cancer metabolism and rare metabolic genetic diseases. |
| Alexion
Pharmaceuticals |
Alexion
pharmaceuticals is focused on the development
of proprietary immunoregulatory technologies for
the treatment of cardiovascular, autoimmune and
neurologic diseases. |
| Alnylam Pharmaceuticals |
Alnylam Pharmaceuticals is focused on the research and development of RNAi therapeutics for infectious diseases and cancer. |
| Amgen |
Amgen
develops therapeutic proteins in oncology/hematopoiesis,
inflammation, and neurobiology/endocrinology. |
| Anchor Therapeutics |
Anchor Therapeutics is focused on development of pepducins for targeting G protein coupled receptors (GPCRs) on the inside surface of the cell membrane. |
| Ariad
Pharmaceuticals |
Ariad
is a leader in the design and development of a
new class of pharmaceuticals that target intracellular
signaling pathways to alter the course of disease. |
| Aura BioSciences |
Aura BioSciences is focused on the research and development of nanosphere particles for oncology drug delivery. |
| AVEO Oncology |
AVEO Oncology is focused on discovering, developing and commercializing novel cancer therapeutics. |
| Bayer |
Bayer develops and markets various
drugs. Oncogene Science, a part of Bayer Healthcare is based in Cambridge. |
| BioAxone BioSciences |
BioAxone BioSciences is focused on the research and development of drugs to treat neurological disorders. |
| Biogen Idec |
Biogen Idec is focused on research, development, and commercialization of products in neurology, oncology and immunology. |
| BIND Therapeutics |
BIND Therapeutics is focused on the research and development of targeted therapeutics using its proprietary AccurinsTM technology. |
| Bluebird Bio |
Bluebird Bio is focused on the research and development of gene therapies for severe genetic disorders. |
| Blueprint Medicines |
Blueprint Medicines is focused on the discovery, research, and development of drugs identified through cancer sequencing and functional studies. |
| Catabasis |
Catabasis is focused on the research and development of medicines for the treatment of inflammatory, immunologic and metabolic diseases. |
| Celexion |
Celexion is focused on using its proprietary SECANT™ platform to discover and engineer new proteins for applications in therapeutics, diagnostics, and life science tools. |
| Cerulean Pharma |
Cerulean Pharma is discovering and developing nanopharmaceuticals (drugs within ultra-small particles) to preferentially directing drug-containing nanoparticles to diseased tissues, resulting in sustained release of the drug in target cells and minimizing systemic exposure. |
| Edimer Pharmaceuticals |
Edimer Pharmaceuticals is focused on the development of EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED). |
| Eleven Biotherapeutics |
Eleven Biotherapeutics is focused on the research and development of protein therapeutics utilizing it's proprietary AMP-Rx product engine. |
| Ensemble Therapeutics |
Ensemble Therapeutics is focused on the research and development of compounds which interfere with protein:protein interactions. |
| Enumeral Biomedical |
Enumeral Biomedical is focused on the discovery of native human monoclonal antibodies using a proprietary high-density bio-chip microarray. |
| Epizyme |
Epizyme is focused on the discovery, research, and development of personalized therapeutics for patients with genetically defined cancers. |
| Eutropics Pharmaceuticals |
Eutropics Pharmaceuticals is focused on the research and development of the proprietary BH3-profiling biomarker to guide cancer treatment. |
| Foundation Medicine |
Foundation Medicine is focused on the development and commercialization of cancer genetic testing to assist in selection of a treatment regimen. |
| Genocea Biosciences |
Genocea Biosciences is focused on the research and development of vaccines that induce T cell immunity. |
| Genosco |
Genosco is focused on the discovery, research and development of small molecule drugs to treat inflammation, cancer and Parkinson’s disease. |
| Genzyme |
Genzyme
is a highly diversified family of companies committed
to redefining patient care worldwide through the
introduction of innovative products and services
for major unmet medical needs. |
| Good Start Genetics® |
Good Start Genetics® is focused on genetic carrier screening for inherited diseases. |
| H3 Biomedicine |
H3 Biomedicine is focused on the research and development of small-molecule drugs to treat cancer. |
| Hydra Biosciences |
Hydra Biosciences is focused on development of drugs targeting ion channels to treat pain, inflammation, cardiovascular and other diseases. |
| Idera Pharmaceuticals |
Idera Pharmaceuticals is focused on the development of TLR agonists as drug candidates to treat infectious diseases, autoimmune and inflammatory diseases, cancer, and respiratory diseases, and for use as vaccine adjuvants. |
| ImmusanT |
ImmusanT is focused on the research and development of a treatment designed to replace a gluten-free diet for celiac disease sufferers. |
| Infinity Pharmaceuticals |
Infinity Pharmaceuticals is focused on the discovery, development, and commercialization of drugs for the treatment of cancer and related conditions. |
| Ironwood Pharmaceuticals |
Ironwood Pharmaceuticals is focused on the research, development, and commrecialization of compounds for treatment of patients with gastrointestinal diseases, central nervous system disorders, respiratory diseases, or cardiovascular diseases. |
| MedinCell |
MedinCell is focused on partnering with pharmaceutical and biotechnology companies to develop long-acting formulations. |
| Merrimack Pharmaceuticals |
Merrimack Pharmaceuticals is focused on the development of medicines for the treatment of autoimmune disease and cancer. |
| Mersana Therapeutics |
Mersana Therapeutics is focused on application of its biodegradable polymer platform (Fleximer®) to drug and biologics development. |
| Metabolix |
Metabolix is focused on the development and commercialization of PHA biopolymers products. |
| Millennium
Pharmaceuticals |
Millennium
Pharmaceuticals, Inc. is a leading drug discovery
and development company, incorporating large-scale
genetics, genomics, high throughput screening
and informatics in an integrated science and technology
platform. |
| Momenta Pharmaceuticals |
Momenta Pharmaceuticals is focused on the research, development, and commercialization of products that are complex mixture generic and novel drugs. |
| Monsanto |
Monsanto produces leading seed brands in large-acre crops like corn, cotton, and oilseeds (soybeans and canola), as well as small-acre crops like vegetables. They also produce leading in-the-seed trait technologies for farmers that are aimed at protecting their yield, supporting their on-farm efficiency and reducing their on-farm costs. |
| Novartis |
Novartis engages in the research, development, and commercialization of a range of healthcare products. |
| NovoBiotic |
NovoBiotic is focused on the research and development of antibiotics using a method for growing previously "unculturable" microorganisms. |
| OvaScience |
OvaScience is focused on the research, development and commercialization of treatments for infertility. |
| PerkinElmer |
PerkinElmer is focused on the development and commercialization of instruments, reagents, software and services for human and environmental health applications. |
| Pfizer |
Pfizer Inc. is involved in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. |
| Quintiles |
Quintiles is a contract research organization focused on providing integrated bio and pharmaceutical services. Quintiles also offers commercial, consulting and capital services. |
| Ra Pharmaceuticals |
Ra Pharmaceuticals is focused on the research and development of a stable, synthetic, peptide-like products that offer intrinsic cell permeability. |
| Radius Health |
Radius Health is focused on the research, development, and commercialization of therapeutics for the treatment of women’s health conditions. |
| Sanofi-Aventis |
Sanofi-Aventis is a large pharmaceutical company focused on the discovery, development, and commercialization of a wide range of drugs. A research and development facility is located in Cambridge. |
| Sarepta Therapeutics |
Sarepta Therapeutics
is involved in developing drugs to treat life-threatening
diseases using third-generation antisense technology. |
| SciFluor Life Sciences |
SciFluor Life Sciences is focused on the research and development of a portfolio of new chemical entities (NCEs) that consist of fluorinated versions of FDA approved small molecule drugs. |
| Taligen Therapeutics |
Taligen Therapeutics is focused on targeted therapies that regulate the complement system to treat inflammatory and immune diseases. |
| Tokai Pharmaceuticals |
Tokai Pharmaceuticals is focused on the research and development of treatments for prostate cancer. |
| Variation Biotechnologies |
Variation Biotechnologies is focused on the research and development of vaccines. |
| Verastem |
Verastem is focused on the research and development of small molecule drugs that selectively target cancer stem cells. |
| Vertex
Pharmaceuticals |
The
Company has 12 drug candidates in development to
treat viral diseases, inflammation, cancer, autoimmune
diseases and neurological disorders. |
| Zafgen |
Zafgen is focused on the research and development of treatments for patients who are severely obese. |
| Zalicus |
Zalicus is focused on the research, development, and commercialization of treatments for pain and inflammatory diseases. |
